Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG4.L Regulatory News (MIG4)

  • There is currently no data for MIG4

Interim Management Statement

11 Nov 2014 14:08

RNS Number : 7294W
Mobeus Income & Growth 4 VCT PLC
11 November 2014
 



Mobeus Income & Growth 4 VCT plc (the Company)

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2014

 

In accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority, Mobeus Income & Growth 4 VCT plc presents an Interim Management Statement for the quarter ended 30 September 2014. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE (NAV) AND TOTAL RETURN PER SHARE

At 30 September 2014

At 30 June 2014

Net assets attributable to shareholders

£48,468,302

£52,878,546

Shares in issue

42,690,195

41,872,204

Net asset value (NAV) per share

113.53*p

126.29p

Cumulative dividends paid

52.20 p

38.20 p

Total return (net asset value basis) per share since inception

165.73p

164.49p

 

\* The fall in the NAV per share of 12.96 pence is mainly due above to the payment of the interim dividend of 14.00 pence per share, detailed below.

 

CUMULATIVE DIVIDENDS

 

The Company paid an interim dividend of 14.00 pence per share (comprising 12.00 pence from capital and 2.00 pence from income) on 12 September 2014, bringing cumulative dividends paid per share to date to 52.20 pence.

 

NEW INVESTMENT

 

In July 2014, the Company completed a new investment of £1.16 million to support the MBO of Tharstern Limited, the UK's leading supplier of software-based management information systems to the print sector.

 

DIVESTMENTS

 

The VCT completed the full realisation of its investment in DiGiCo Global Limited in July 2014 through a sale to a new professional audio group backed by Electra Partners, generating net cash proceeds of £1.73 million. The total proceeds received by the VCT over the life of this investment of £5.49 million represent a return on investment of 5.49 times original cost of £1.00 million.

 

Following the period-end, the VCT has realised its investments in Focus Pharma Holdings Limited and Youngman Group Limited for net cash proceeds of £1.53 million and £0.81 million respectively. The Company received total proceeds over the life of its investment in

Focus of £2.88 million, representing a return of 3.74 times original cost of £0.77 million. Similarly, over the life of the investment in Youngman, total proceeds of £1.21 million were generated, representing a return of 2.42 times original cost of £0.50 million

 

LOAN STOCK REPAYMENTS

 

A total of £0.15 million has been received in loan stock repayments during the quarter to 30 September 2014, including payments from Tessella Holdings Limited, Westway Services Holdings (2010) Limited and Virgin Wines Holding Company Limited. 

 

A further £0.05 million was received from Fullfield Limited (Motorclean) and Tharstern Limited following the period-end.

 

SHARE BUY-BACKS

 

The Company did not buy back any of its own shares during the quarter ended 30 September 2014. After the period, on 1 October 2014, 110,000 shares were bought back for cancellation. Following this repurchase of shares, there were 42,580,195 Ordinary shares in issue.

 

FUNDRAISING

 

The Company has announced its intention to launch an offer for subscription later this year to raise up to £6 million.

 

The offer will be promoted by Mobeus Equity Partners LLP, the investment adviser to the Company, and will be made alongside similar offers from Mobeus Income & Growth VCT plc, Mobeus Income & Growth 2 VCT plc and The Income & Growth VCT plc.

 

 

For further information, please contact:

Jonathan McGuire, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZFLFFZFFBFBQ
Date   Source Headline
16th Apr 20205:45 pmRNSAnnual Financial Report
16th Apr 20205:45 pmRNSDividend Investment Scheme - Recommencement
2nd Apr 20205:10 pmRNSIssue of Equity
2nd Apr 202010:00 amRNSDividend Declaration
30th Mar 202012:51 pmRNSPublication of Suppl.Prospcts
27th Mar 20207:00 amRNSNet Asset Value(s)
25th Feb 20203:15 pmRNSPublication of Suppl.Prospcts
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
7th Feb 20206:40 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:37 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:36 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:34 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:30 pmRNSPublication of Suppl.Prospcts
3rd Feb 202011:30 amRNSTotal Voting Rights
8th Jan 20204:31 pmRNSFundraising Update
8th Jan 20204:20 pmRNSIssue of Equity & Total Voting Rights
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
13th Dec 20195:50 pmRNSDividend Declaration
13th Dec 20199:15 amRNSTransaction in Own Shares
27th Nov 20194:15 pmRNSInterim Management Statement - 3rd Quarter Results
27th Nov 20191:52 pmRNSDividend Declaration
26th Nov 20195:00 pmRNSDirectorate Change
19th Nov 201912:00 pmRNSFundraising Update
25th Oct 20194:00 pmRNSPublication of a Prospectus
21st Oct 201912:57 pmRNSDirector Declaration
11th Oct 20193:00 pmRNSResult of Meeting
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
10th Sep 20195:00 pmRNSFundraising Update, Circular and General Meetings
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
14th Aug 201911:05 amRNSNational Storage Mechanism
8th Aug 201910:54 amRNSHalf-year Report
31st Jul 20197:00 amRNSReduction of Capital
29th Jul 201911:00 amRNSShare buyback policy objective
29th Jul 20197:00 amRNSIntention to launch offers for subscription
3rd Jul 201911:33 amRNSRealisation of investment
20th May 20199:28 amRNSTransaction in Own Shares
15th May 201910:16 amRNSTransaction in Own Shares
13th May 201910:10 amRNS1st Quarter Results - Interim Management Statement
10th May 20192:08 pmRNSDirectorate Change
10th May 20192:05 pmRNSResult of AGM
27th Mar 201910:48 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.